Abstract-Recent reports indicate that, in addition to treating hypertension, renal denervation (RDN) also mitigates renal inflammation. However, because RDN decreases renal perfusion pressure, it is unclear whether these effects are because of the direct effects of RDN on inflammatory signaling or secondary to decreased arterial pressure (AP). Therefore, this study was conducted to elucidate the contribution of renal nerves to renal inflammation in the deoxycorticosterone (DOCA)-salt rat, a model in which RDN decreases AP and abolishes renal inflammation. In Experiment 1, we assessed the temporal changes in renal inflammation by measuring renal cytokines and AP in DOCA-salt rats. Uninephrectomized (1K) adult male Sprague Dawley rats that received surgical RDN or sham (Sham) were administered DOCA (100 mg, SC) and 0.9% saline for 21 days. AP was measured by radiotelemetry, and urinary cytokine excretion was measured repeatedly. In Experiment 2, the contribution of renal nerves in renal inflammation was assessed in a 2-kidney DOCA-salt rat to control for renal perfusion pressure. DOCA-salt treatment was administered after unilateral (U-)RDN. In Experiment 1, DOCA-salt-induced increases in AP and renal inflammation (assessed by urinary cytokines) were attenuated by RDN versus Sham. In Experiment 2, GRO/KC (growth-related oncogene/keratinocyte chemoattractant), MCP (monocyte chemoattractant protein)-1, and macrophage infiltration were lower in the denervated kidney versus the contralateral Sham kidney. No differences in T-cell infiltration were observed. Together, these data support the hypothesis that renal nerves mediate, in part, the development of renal inflammation in the DOCA-salt rat independent of hypertension. The mechanisms and cell-specificity mediating these effects require further investigation.
H ypertension remains the greatest risk factor for cardiovascular disease and is the most common cause of morbidity and mortality worldwide. 1 While the cause of hypertension is multifaceted, the principal role for increased sympathetic nerve activity, particularly to the kidney, is extensively documented in both clinical and experimental settings. [2] [3] [4] In recent years, particular attention has focused on renal sympathetic nerves because renal denervation (RDN) attenuates and reverses several experimental models of hypertension. 4, 5 These findings were translated to the first clinical trials 6, 7 in which catheter-based RDN decreased arterial pressure (AP) in hypertensive patients. Predictably, these trials generated a large amount of interest and excitement for this alternative approach to treat resistant hypertension. In recent years, several clinical studies [8] [9] [10] [11] [12] [13] [14] [15] consistently report a significant and lasting antihypertensive response, most notably in the SPYRAL HTN-OFF MED, SPYRAL HTN-ON MED, and RADIANCE trials. 16, 17 The mechanisms mediating the antihypertensive effects of RDN remain undefined but initially were believed to result from loss of neural control of renin release, renal vascular resistance, and tubular sodium reabsorption. 5 An alternate hypothesis has emerged which points to renal nerves as primary mediators of immune cell trafficking, infiltration, and activation in the kidney. This results in renal inflammation and concomitant renal dysfunction. 18, 19 Specifically, Xiao et al 18 first reported that T-cell infiltration following 14 days of angiotensin II treatment in mice was ameliorated by RDN, providing strong evidence for a role of renal sympathetic nerves in mediating renal inflammation in hypertension.
Consistent with this hypothesis, we recently reported RDN attenuates renal inflammation during the development of deoxycorticosterone (DOCA)-salt hypertension. 20 Specifically, RDN abolished DOCA-salt-induced increases in several proinflammatory cytokines in the kidney, and this was correlated with a 50% reduction in AP compared with control rats. 20 However, in a follow-up study, we found that although RDN reduced AP in rats with established DOCA-salt hypertension, it had no effect on renal cytokines. 21 When combined these studies suggest that although renal nerves are required for the development of renal inflammation in DOCA-salt rats, they play no role in maintaining inflammation once it is established.
Although these studies did not address the mechanism by which RDN influences the development of renal inflammation in the DOCA-salt rat, we envision at least 2 general possibilities. The first is that renal nerves (afferent or efferent) may directly influence trafficking of immune cells into the kidney 18, 22 independent of any other physiological response to RDN. This stimulatory action would be lost after RDN. The second is that, because increased renal perfusion pressure is a known cause of renal inflammation, 23, 24 loss of renal nerves via RDN may reduce renal inflammation simply by lowering systemic AP.
The primary goal of the present study, therefore, was to delineate the individual contributions of renal nerves and renal perfusion pressure to the pathogenesis of renal inflammation in DOCA-salt rats. Moreover, we sought to establish the feasibility of serial measurements of urinary cytokines as a biomarker of renal inflammation during the development of DOCA-salt hypertension in conscious rats.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. All procedures were approved by the University of Minnesota IACUC and in compliance with the National Institutes of Health Guide for Care and Use of Laboratory Animals. Animals were housed in a temperature-and humidity-controlled room (70°-72°F; 30%-35%) with a 12-hour on/ off light schedule. Animals had ad libitum access to chow (Teklad 2018; Envigo) and distilled water. All surgical procedures were performed under 2% to 3% isoflurane anesthesia (Phoenix Pharmaceutical). Pharmacological prophylactic care included atropine (0.2 mg/kg, IP; West-Ward Pharmaceuticals), ketoprofen (5 mg/kg, SC; Fort Dodge Animal Health), and gentamicin (2.5 mg/kg, IM; Hospira) administration before each surgery. These experiments were conducted using the DOCA-salt rat model, a well-established preclinical model that recapitulates moderate to severe salt-sensitive hypertension and renal dysfunction. 25 Timelines of the experimental protocols are depicted in Figure 1A and 1B, and further defined below.
Experiment 1: Temporal Relationship Between Renal Inflammation and AP in DOCA-Salt Rat
The timeline for this protocol is shown in Figure 1A . Sixteen uninephrectomized male Sprague Dawley rats (weight: 275-300 g; age: 10-12 weeks) were anesthetized (2%-3% isoflurane) and randomly assigned to 1 of 2 treatment groups: 1K-DOCA-salt + RDN (n=8) and 1K-DOCA-salt + sham denervation (Sham; n=8). RDN was achieved by a 2-step procedure, as follows: (1) surgical ablation of visible renal nerves bundles along the renal artery and vein and (2) chemical ablation by perivascular application of 10% phenol (in 100% ethanol). Sham surgeries were treatment with 0.9% saline application. 20 All animals were also instrumented with radiotelemeters (Model HD-S10, Data Sciences International) at the time of RDN/Sham surgery, where catheters were introduced to the abdominal aorta via femoral artery cannulation.
One week following RDN/Sham, each group began a 3-week DOCA-salt treatment as we have previously published. 20, 26, 27 Animals were briefly anesthetized, and a silicone pellet containing 100 mg DOCA was implanted subcutaneously and drinking water was replaced with 0.9% saline.
AP and heart rate (HR) were measured over 24 hours on protocol days 0, 3, 7, 14, and 21. On the same day as AP measurements urine was collected for analysis of inflammatory cytokines. To attain these samples, the rats were transferred to a metabolic cage, and urine was collected for 4 hours over ice (0800-1200 hours). Rats were then returned to their home cages, and 24-hour AP and HR were collected (1200-1200 hours). Rats were conditioned to this procedure 3 days before the start of the experimental protocol. After 21 days of treatment, animals were acutely anesthetized (5% isoflurane) and euthanized by decapitation. Allometric data were recorded, and urine and renal tissue samples were collected and snap-frozen for further analysis.
Experiment 2: Effect of Unilateral RDN on Renal Inflammation in 2K-DOCA-Salt Rats
The timeline for this protocol is shown in Figure 1B . This experiment was designed to assess the inflammatory profile of a DOCA-salt kidney exposed to increased renal perfusion pressure in the presence and absence of renal nerves. Therefore, in contrast to Experiment 1 that was conducted in uninephrectomized (1K) DOCA-salt rats, this experiment used the 2-kidney DOCA-salt (2K-DOCA) model, thereby enabling us to compare an intact kidney to a denervated kidney from the same animal. Importantly, in this setting, both kidneys are exposed to the same perfusion pressure throughout the protocol even though typically AP does not increase as much as observed in the 1-kidney model.
Ten male Sprague Dawley rats (weight: 275-300 g; age: 10-12 weeks) underwent a unilateral RDN (U-RDN) as described above. The contralateral kidney (right) underwent a sham procedure (U-Sham). A radiotelemetry transmitter was implanted at this time to measure AP and HR. Next, rats received 100 mg DOCA implants (SC) and 0.9% saline for drinking water and were then monitored for 21 days. After the 21-day DOCA-salt treatment, each rat underwent an acute surgical preparation to collect urine from each kidney, followed by necropsy. Animals were anesthetized and maintained with 2% to 3% isoflurane, and each ureter was cannulated (PE10; BD Intramedic). After a 10-minute stabilization period, urine samples from each ureter were collected simultaneously on ice over 30 minutes. Rats were then euthanized by exsanguination and pneumothorax. Allometric data were recorded, and tissue samples were dissected and snap-frozen for further analysis.
Biochemical and Histological Analysis of Renal Inflammation
The inflammatory profiles for Experiments 1 and 2 were determined by measuring several proinflammatory chemokines and cytokines in renal tissue and urine. Specifically, we measured IL (interleukin)-1β, IL-2, IL-6, MCP (monocyte chemoattractant protein)-1, and GRO/KC (growth-related oncogene/keratinocyte chemoattractant). These inflammatory cytokines and chemokines have previously been shown to be elevated in DOCA-salt kidneys. 20, 21 Renal tissue samples (mixed cortex and medulla) were homogenized in PBS containing Ethylenediaminetetraacetic acid-free protease inhibitor cocktail (complete mini; item: No. 11836170001; Roche Diagnostics). Inflammatory cytokines were measured by Luminex assay according to the manufacturer's instructions (MILLIPLEX Custom Assay, MilliporeSigma). Data are expressed in picograms of analyte per milligrams of total protein (tissue) or milligrams of creatinine (urine). Total protein from tissue and urine samples was measured by a bicinchoninic acid kit (Thermo Scientific). Urine creatinine was quantified by commercial kit according to the manufacturer's directions (Cayman Chemical).
Kidney samples were also collected for histological assessment of injury and inflammation, as previously described. 21 At necropsy, kidneys were excised and bisected, fixed in 10% formalin for 24 to 48 hours, and embedded in paraffin wax. Tissues were sectioned and stained by the University of Minnesota Veterinary Diagnostic Laboratory. Transverse sections (4 µm thickness) were stained for anti-CD3 (T cells) or anti-Iba1 (macrophage) antibodies. Primary polyclonal antibodies were used to detect T cells (anti-CD3; No. CP215; Biocare Medical) and macrophages (anti-Iba1; No. CP290; Biocare Medical). A peroxidase-labeled polymer conjugated to goat anti-rabbit Ig secondary antibody (EnVision+HRP; Agilent/ Dako Corp) was used as the detection reagent and 3-Amino-9-Ethylcarbazole as the chromogen. Last, slides were counterstained with Mayer hematoxylin and photographed using a Nikon Eclipse outfitted with a Nikon DS-Fi1 digital color camera. Signal was quantified automatically as %area from scanned slides at ×10 magnification using methods outlined by Ruifrok and Johnston 28 using ImageJ Software. 29 
Confirmation of RDN
Renal norepinephrine content was measured to assess completeness of efferent renal sympathetic nerve ablation. Tissue homogenates were assayed by high-performance liquid chromatography analysis with electrochemical detection, as previously described. 30 Data are expressed as nanograms of norepinephrine per gram of tissue.
Statistical Analysis
Repeat measurements from Experiment 1 were analyzed separately by a 2-way repeated-measured ANOVA with a Bonferroni post hoc test to assess treatment effects (Sham versus RDN) at matched time points. Additionally, time-dependent changes from baseline (vs day 0) within each treatment group were assessed by a 1-way repeated measures ANOVA with a Dunnett post hoc test. All nonrepeated measures data were analyzed by an unpaired Student t test (2-tailed). Data collected in Experiment 2 were analyzed by a paired Student t test (2-tailed), comparing the ipsilateral treated tissues to contralateral sham controls (U-RDN versus U-Sham). Statistical analyses were performed with GraphPad Prism 7.0 software. Statistical significance was accepted at P<0.05. Data are presented as mean±SEM.
Results

Experiment 1: Temporal Relationship Between Renal Inflammation and AP in DOCA-Salt Rat
Cardiovascular and Allometric Responses
Before the DOCA implant, no significant differences were detected between Sham and RDN groups about baseline 24-hour averages of AP (105±2 versus 96±3 mm Hg) or HR (380±8 versus 356±6 bpm). After DOCA-salt administration, AP increased to 166±5 mm Hg over 3 weeks in the Sham group compared with 136±8 mm Hg (P<0.05) in the RDN group (Figure 2) . No effect of treatment or time on HR was detected between or within Sham and RDN groups (Figure 2) . Moreover, no effect was observed between Sham and RDN in daily sodium intake throughout 3-week protocol (21.8±1.3 versus 24.4±2.5 mmol/d).
On protocol completion, there were no differences between groups for body weight or heart weight in contrast to kidney weight, which was significantly less in RDN compared with Sham rats (5.80±0.18 versus 6.60±0.24 g/kg body weight).
Renal Inflammation and Urinary Cytokines
Renal inflammation was assessed biochemically and histologically. First, proinflammatory cytokines were quantified by repeated measurements in urine throughout the 21-day treatment, as well as in renal parenchymal tissue at the end of the protocol (Figure 3) . Compared with Sham, at the end of the protocol, all renal inflammatory cytokines measured (IL-1β, IL-2, IL-6, MCP-1, and GRO/KC) were substantially reduced (↓44%-84%) in RDN kidney tissue (Figure 3 , left panel) similarly to our previous study. 20 A novel aspect of this study was the measurement of urinary cytokines as a real-time biomarker of renal inflammation in conscious rats (Figure 3, right panel) . Repeated measurements of urinary cytokine excretion over the 3-week protocol revealed a time-dependent increase in urinary cytokine excretion in response to DOCA-salt treatment in Sham rats. In contrast, there was no significant increase in urinary cytokine excretion in RDN rats in response to DOCA-salt treatment with the exception of MCP-1 at day 21. Importantly, the magnitude of differences in urinary cytokine excretion on day 21 between Sham and RDN rats (IL-1β ↓66%; IL-2 ↓67%; IL-6 ↓53%; MCP-1 ↓46%; and GRO/KC ↓70%) were similar to that measured in renal tissue (IL-1β ↓50%; IL-2 ↓52%; IL-6 ↓44%; MCP-1 ↓69%; and GRO/KC ↓84%). UPCR (urinary protein-to-creatinine ratio), a measurement of renal injury, increased over time in both groups compared with their respective baseline, but UPCR was significantly lower in RDN at protocol days 14 and 21 ( Figure 3B ).
Immunohistochemical detection of immune cell markers was performed to quantify immune cell (T cell and macrophage) infiltration of Sham and RDN kidneys after 21 days of DOCA-salt treatment (Figure 4 ). Both macrophage (Iba1+) and T-cell (CD3+) infiltration were markedly lower in RDN compared with Sham samples.
Confirmation of RDN
Renal norepinephrine content was quantified to determine the efficacy of RDN treatment. Compared with Sham (81.2±6.8 ng/g tissue), RDN renal norepinephrine content was reduced by >90% (7.5±2.1 ng/g). These data confirm that a majority of efferent sympathetic nerves were successfully ablated by RDN.
Experiment 2: Effect of Unilateral RDN on Renal Inflammation in 2K-DOCA-Salt Rats
Cardiovascular and Allometric Responses
After 3 weeks of DOCA-salt treatment, 24-hour mean AP increased from 102±3 (protocol day 0) to 136±4 mm Hg (protocol day 21). On protocol day 21, rats were anesthetized and urine was collected from each kidney over ice for 30 minutes before euthanasia and necropsy. No significant effect on kidney weight was detected between U-Sham and U-RDN (3.85±0.23 versus 3.76±0.18 g/kg body weight). Similarly, no differences in urinary flow rate (16.0±1.0 versus 17.7±1.4 µL/min per 100 g body weight) nor protein-to-creatinine ratio (1.92±0.27 versus 1.73±0.17 arbitrary units) were detected between U-Sham and U-RDN kidneys.
Renal Inflammation and Urinary Biomarkers
Quantification of renal tissue lysate and urinary cytokine content revealed a differential effect of RDN on inflammatory markers ( Figure 5 ). Specifically, in both renal and urine measurements, there were no differences between U-Sham and U-RDN kidneys for IL-1β, IL-2, and IL-6 levels. However, there was a significantly lower level of chemotactic cytokines MCP-1 and GRO/KC in the U-RDN versus the U-Sham, in both urine and renal tissue.
Furthermore, immunohistochemical analysis of renal macrophage and T-cell infiltration was used to determine the selective effects of RDN, independent of the effect of changes in AP. Macrophage infiltration was significantly reduced in U-RDN kidneys compared with U-Sham ( Figure 6 ). This effect of RDN seems to be specific to macrophages, as no difference in T-cell infiltration was detected between U-RDN and the contralateral U-Sham kidneys ( Figure 6 ). 
Confirmation of RDN Efficacy
Renal norepinephrine content was quantified to determine the effectiveness of RDN treatment. Compared with U-Sham, norepinephrine content in U-RDN kidneys was lowered substantially (95.3±10 versus 9.0±3.1 ng/g tissue). These data confirm the vast majority (>90%) of sympathetic nerves were ablated by surgical RDN.
Discussion
These studies were designed to delineate the relationship between renal innervation and renal perfusion pressure in the pathogenesis of renal inflammation in the DOCA-salt rat. First, the findings in this study confirm our previous report that RDN in large part prevents the development of renal inflammation in the DOCA-salt rat. Second, the present study suggests that renal nerves directly modulate renal macrophage activation and infiltration in contrast to T cells which are not affected by RDN. Last, this study also reveals urinary cytokines may serve as a real-time biomarker of renal inflammation in the rat. These findings are discussed in more detail in the following sections.
Temporal Relationship of AP and Renal Inflammation Responses in DOCA-Salt Rats
The cause and effect relationship between renal inflammation and hypertension is unknown, in part, because renal inflammation is usually assessed only at a single time point using standard renal histopathologic and biochemical methods. 31 In Experiment 1, we investigated the utility of measuring urinary cytokines as a real-time biomarker of renal inflammation in DOCA-salt rats. Urinary cytokines were measured before 7, 14, and 21 days following the start of DOCA-salt treatment. In addition, on day 21 of DOCA-salt, we directly compared immune cell (macrophage and T cell) infiltration and proinflammatory cytokine content in the kidneys to urinary cytokine excretion.
We observed that urinary cytokine excretion increased in parallel to AP in DOCA-salts rats. In addition, the proportional changes in renal tissue proinflammatory cytokine content observed in Experiment 1 and Experiment 2 were mirrored by urinary cytokine excretion, despite differences in the magnitudes of hypertension. Interestingly, urinary cytokine excretion (IL-1β, IL-2, IL-6, MCP-1, and GRO/KC) was markedly elevated following 21 days of DOCA-salt treatment in Sham rats but not RDN rats. In fact, apart from MCP-1, the DOCA-salt-induced increases in cytokine excretion were abolished in RDN rats.
Despite an elevation of ≈30 mm Hg AP by day 7 of DOCAsalt in Sham rats, no changes in urinary cytokines were detected until day 14. Note, however, that AP increased an additional ≈30 mm Hg from days 7 through 14, and this coincided with a parallel increase in urinary cytokine excretion at days 14 and 21. Because of the sampling rate of AP and urinary cytokines over time, we cannot conclude whether renal inflammation was the cause or consequence of increased renal perfusion pressure in this model. Further experiments with higher sampling rates are required to elucidate this sequential relationship.
There are previous reports in which urinary cytokine excretion was measured in parallel to AP, but few have made repeated observations over time. 32 Immunosuppression therapy, targeting T-cell activation with mycophenolate mofetil, in hypertensive patients with autoimmune disease reduced systolic blood pressure and urinary TNF-α excretion. The final systolic AP was also positively correlated with urinary cytokine excretion (ie, TNF-α and RANTES) following mycophenolate mofetil treatment. 32 Urinary excretion of IL-1β, IL-6, and MCP-1 is elevated in adolescents with an idiopathic nephrotic syndrome that also present with impaired renal function and hypertension. [33] [34] [35] Interestingly, repeated measurements of urinary cytokines have previously been suggested to reflect renal-specific inflammatory signaling in the nephrotic model. 34 Finally, urinary excretion of MCP-1 was elevated in rats undergoing 21-day DOCA-salt treatment, coinciding with increased renal immune cell infiltration and cortical inflammatory signaling. 36 
Differential Effect of RDN on Renal Proinflammatory Cytokines
To delineate the contributions of increased renal perfusion pressure and renal nerves to renal inflammation, we conducted a study in 2K DOCA-salt rats that underwent a unilateral RDN. This experiment produced 2 key findings.
First, macrophage infiltration was specifically reduced in the denervated kidney compared with the contralateral innervated kidney, despite the kidneys experiencing the same renal perfusion pressure. This effect was unique to macrophages, as T-cell infiltration was similar between U-RDN and U-Sham kidneys. We conclude that T-cell infiltration is likely independent of renal innervation, whereas macrophage infiltration may be partially nerve dependent. Potential mechanisms mediating the trafficking and putative activation of these macrophage could be through direct cell-to-cell interaction with renal nerves or through neurotransmitter paracrine signaling [37] [38] [39] [40] ; however, the underlying mechanisms remain to be studied.
Second, proinflammatory urinary cytokine excretion was also reduced in the denervated kidney, specifically for the chemotactic cytokines MCP-1 and GRO/KC. Because these cytokines are secreted by macrophages, and less by T cells, we speculate the reduction in macrophage infiltration in RDN kidneys is the chief cause of the decreased cytokine levels in both the kidney and urine. Whether renal sympathetic nerves are the primary arbiters of recruitment, and activation of macrophages in the kidney requires further investigation.
Inferences about the pathways involved in neural-mediated macrophage recruitment can be drawn from reports from Kim and Padanilam, 39, 40 who observed a comparable role for efferent and afferent renal nerves in the macrophage infiltration and fibrogenesis in a murine model of renal inflammation in a unilateral ureteral obstruction and in a model of ischemia-reperfusion injury. In this unilateral ureteral obstruction model, RDN obviated the inflammation and fibrosis developed after 10 days of unilateral ureteral obstruction. Moreover, chronic cortical infusion of either norepinephrine (efferent neurotransmitter) or CGRP (calcitonin-gene related peptide; afferent neurotransmitter) after RDN effectively restored the nephritic response to unilateral ureteral obstruction. 40 Though the cortical infusion used in the these studies 39, 40 did not control for final location of delivery and dispersion across the kidney, these data strongly support the role for efferent and afferent neurotransmitters in the recruitment and activation of inflammatory mediators such as macrophages under 2 different inflammatory stimuli. In addition to the development of neurogenic inflammation, Barry and Johns 41 reported renal afferent nerve activation with proinflammatory peptide bradykinin elicited a sympathoexcitatory reflex, which suggests renal afferent nerves and inflammation may have a reciprocal relationship. Considering that afferent renal nerve activity is elevated in the hypertensive 1K DOCAsalt rat, 20 paired with increased renal inflammation, further studies are necessary to elucidate the mechanism and interplay between renal inflammation and afferent renal nerves.
Though the current investigation did not include normotensive rats that underwent unilateral RDN, we speculate the tonic sympathetic tone does not significantly contribute to basal inflammatory cytokine signaling in the kidney under normal conditions. This is based on the lack of difference observed at baseline (day 0) in urinary cytokines excretion between the 1K-DOCA Sham and RDN rats. Similarly, Arsenijevic et al 42 demonstrated unilateral RDN in healthy male Sprague Dawley rats had no significant effect on any cytokines measured in renal tissue (eg, IL-6, interferon gamma, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor) compared with the contralateral control kidney. Unilateral denervation reportedly increases ipsilateral pelvic pressure, putatively due to an enhanced diuresis. 43 The diuretic effect is likely mediated by a combination of decreased renal vascular resistance and decreased sodium/water reabsorption in the proximal tubule following unilateral RDN, both of which are maintained by renal sympathetic nerve discharge. [44] [45] [46] In Experiment 2, we did not detect any difference in urinary flow in the 2 kidneys after 21 days of DOCAsalt treatment. Moreover, Shweta et al 47 reported estimated glomerular capillary pressure was slightly reduced (47 versus 50 mm Hg) in the denervated kidney versus innervated kidney in spontaneously hypertensive rats following U-RDN. Although we did not perform micropuncture measurements in the present study, we feel it is unlikely that differences in glomerular capillary pressure are responsible for differences in renal inflammation observed between the U-Sham and U-RDN kidneys.
Pressure-Dependent Renal Inflammation
Pressure-mediated inflammation and end-organ damage have long been recognized as cardinal features of hypertension and renal disease. 48 The relationship between AP and renal pathology has been thoroughly investigated. 23, 24 Of note, Evans et al 23 have demonstrated that AP is a primary mediator of renal injury and T-cell infiltration in the Dahl SS hypertensive rat. In their study, renal perfusion pressure was maintained at ≈125 to 130 mm Hg in one kidney by continuous servo-control during 7 days of salt-induced hypertension, whereas the contralateral kidney was exposed to steadily rising perfusion pressures (≈140-160 mm Hg). Compared with the hypertensive kidney, inflammatory T-cell infiltration was substantially lower in the pressure-controlled kidneys. Similar effects on macrophage infiltration were also reported by the same group in a separate study. 24 Importantly, the servo-controlled renal perfusion pressure in these studies is nearly identical to what was achieved in the Sham and RDN animals in Experiment 1, as well as differences between the 1K-and 2K-DOCA models. With the higher pressures of 150 to 160 mm Hg of the Sham group in Experiment 1, increased urinary cytokine excretion was also significantly elevated. Combined, these data suggest that a threshold of AP above 130 to 140 mm Hg may be required to initiate or exacerbate renal inflammation.
In the present study, as well as a previous report from our laboratory, 20 we found RDN markedly attenuated renal cytokine content in DOCA-salt rats. Based on the studies discussed above, it is possible this anti-inflammatory effect of RDN is simply because of a decrease in renal perfusion pressure. However, it is important to recognize AP remained elevated above control levels in RDN rats, even when urinary cytokine excretion remained unchanged from baseline. Moreover, in our previous study, 20 renal cytokine levels in RDN DOCA-salt rats were not different from normotensive control rats, despite the fact their AP was higher (+15-20 mm Hg). Indeed, histological and biochemical analyses of renal cytokine content and immune cell infiltration in the current study demonstrate that RDN abated the renal inflammatory response to DOCA-salt. To this end, increased renal inflammation seems not to be obligatory for the moderate increase in AP (20-30 mm Hg) in the RDN rats of Experiment 1. Though the role of renal inflammation contributing to the increase of 20 to 30 mm Hg of AP in RDN rats cannot be ruled out, these studies clearly demonstrate an important role of renal nerves in the pathogenesis of DOCAsalt hypertension. Indeed, the measurements of inflammation are limited to the methods and targets used in this study, and we cannot rule out changes in other inflammatory cells and cytokines that were not measured. Additionally, direct inflammatory effects of mineralocorticoids 49 and increased sodium intake 50, 51 have been previously reported and likely contribute to the inflammatory phenotype in the models used in this study. This relationship and the interplay between sodium, mineralocorticoids, and renal nerves remain a future avenue for investigation.
Perspectives and Significance
These data demonstrate the importance of renal nerves in the development of renal inflammation in the rat model of DOCA-salt hypertension. Our findings particularly implicate renal nervemediated increases in macrophage infiltration and associated proinflammatory cytokine release. Together, these studies reveal a potential relationship and mechanism between renal nerves and renal inflammation under hypertensive conditions. Although it remains to be studied, these anti-inflammatory effects of RDN may extend beyond hypertension in the prophylaxis or treatment of other diseases associated with renal inflammation, such as acute kidney injury or chronic kidney disease.
